InspireMD Inc Stock News

PMA based on overwhelmingly positive results from the pivotal C-GUARDIANS clinical study that were first presented at LINC 2024 in May

InspireMD, Inc. (NASDAQ:NSPR ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Chuck Padala - IR, Life Advisors Marvin Slosman - CEO Craig Shore - CFO Shane Gleason - CCO Conference Call Participants Adam Maeder - Piper Sandler Frank Takkinen - Lake Street Capital Markets Operator Good morning, and welcome to the InspireMD Second Quarter 2024 Earnings Call. Curre...

- Announced positive outcomes from the C-GUARDIANS IDE clinical trial of the CGuard™ Prime carotid stent system demonstrating a one-year primary endpoint event rate of 1.95%, the lowest for any carotid stent or embolic protection device pivotal trial –

CGuard was the only investigational carotid stent approved by FDA for inclusion in the trials CREST-2 included 23 cases implanted with CGuard TEL AVIV, Israel and MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today congratulated the lead investigators on the completion of enro...

-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, and MIAMI, July 30, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report second quarter 2024 financial results on Tuesday, August 6th, before the fin...

Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial

InspireMD Inc. (NASDAQ:NSPR ) Q1 2024 Results Conference Call May 14, 2024 8:30 AM ET Company Participants Chuck Padala - Managing Director Marvin Slosman - President, CEO & Director Craig Shore - CFO, Chief Administrative Officer, Secretary & Treasurer Conference Call Participants Adam Maeder - Piper Sandler Operator Greetings, and welcome to the InspireMD First Quarter 2024 Earnings Call. At ...

- Generated first quarter 2024 CGuard EPS revenue of $1.51 million, an increase of 22.0% over the first quarter of 2023 -